In the BioHarmony Drug Report Database

"Preview" Icon

Droxidopa

Northera (droxidopa) is a small molecule pharmaceutical. Droxidopa was first approved as Northera on 2014-02-18. It is used to treat orthostatic hypotension in the USA. It is known to target muscarinic acetylcholine receptor M1.

 

Trade Name

 

Northera
 

Common Name

 

droxidopa
 

ChEMBL ID

 

CHEMBL2103827
 

Indication

 

orthostatic hypotension
 

Drug Class

 

Dopamine receptor agonists

Image (chem structure or protein)

Droxidopa structure rendering